73 trends tracked about this subject — the full history, oldest to newest below.
Experimental drug retatrutide cut knee osteoarthritis pain by half for nearly 70% of patients across two clinical trials while also reducing body weight.
An experimental weight-loss drug significantly eased knee pain in two major new trials, according to coverage from Everyday Health.
Eli Lilly's experimental triple-hormone drug retatrutide cut knee osteoarthritis pain and produced average weight loss of roughly 25% in two Phase 3 trials involving more than 1,000 adults with obesity.
A major Cleveland Clinic-led trial reveals that a targeted drug successfully lowered lipoprotein(a) without reducing major heart events.
Medical experts are stunned after the promising cholesterol drug pelacarsen unexpectedly fails a key study, leading to its abandonment.
A new AI-powered blood test called LiquidTransformer matches the accuracy of magnetic resonance elastography in staging MASH and identifying treatment candidates, according to data presented at The Liver Meeting.
Novartis faces a multi-billion dollar financial hit from clinical trial setbacks yet maintains financial guidance.
Coverage highlights a clinical trial showing a simple wall or squeezing exercise can help lower blood pressure.
Artiva Biotherapeutics is discontinuing its autoimmune cell therapy and cutting 94 percent of its staff following patient deaths.
A psychedelic nasal spray derived from a toad venom compound shows rapid promise for easing stubborn depression in clinical trials.
A brief, intensive treatment for Obsessive Compulsive Disorder is reporting dramatic results in New Zealand following a successful German clinical trial.
An investigational triple-action weekly weight-loss drug significantly reduces obstructive sleep apnea severity in late-stage clinical trials.
Marengo Therapeutics' Invikafusp alfa shows promise in treating TMB-H solid tumors resistant to standard immune checkpoint blockade.
Government funding targets clinical trials for Alzheimer's disease prevention as blood tests loom.
Researchers explore the health impacts of sauna use, from clinical trials on depression to long-term studies on life extension.
Recent coverage examines clinical AI evaluation, highlighting linguistic inequity, safety risks, and reporting completeness.
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A simple daily pill met its goals in a late-stage trial, raising prospects for halting Parkinson's disease before onset.
A Lancet‑backed trial finds Google’s AMIE chatbot safely handled 98 patient chats, sparking debate on AI’s role in urgent and primary care.
Funding delays from the Trump administration threaten vital clinical trial infrastructure for HIV research.
Cerevance secures a pivotal phase 3 trial win, rescuing its Parkinson's disease drug and inspiring new hope in patients.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The oncology community is facing critical questions as divergent trial results emerge regarding the efficacy and scale of cancer vaccines.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A novel injectable drug called CBL-514 is drawing attention for reducing visceral fat and targeting fat cells without Ozempic or surgery.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
UniQure shares tumble significantly as clinical trial data for its Huntington’s gene therapy draws conflicting reports.
Enveda secures $311 million in venture funding to advance nature-derived AI drugs into clinical trials.
Medical artificial intelligence faces an escalating proof problem as analysts demand randomized controlled trial standards before clinical integration.
A University of Utah graduate fighting stage 4 cancer is traveling to Washington D.C. to advocate for expanded clinical trial access and research funding.
The failure of heart drug trials from pharmaceutical giants Novartis and Novo Nordisk creates a significant setback for a promising field of medicine.
Bristol Myers Squibb reports successful Phase 2 results for its next-generation GPRC5D-directed CAR-T therapy targeting heavily treated myeloma patients.
A common arthritis medication, Upadacitinib, has demonstrated the ability to restore up to 100% of hair in patients suffering from severe alopecia areata.
A clinical trial has indicated that a drug developed through artificial intelligence may have the capacity to make patients biologically younger.
Rapid advancements in medical research and a surge in clinical trials have positioned an Alzheimer's cure as a tangible possibility for the first time.
Novo Nordisk faces a divergent clinical outlook as its pediatric obesity trials succeed while heart drug programs for CKD suffer setbacks.
Healthcare is navigating a critical gap as AI adoption accelerates faster than the governance and cybersecurity frameworks needed to support it.
Novo Nordisk has halted two clinical trials for Ziltivekimab, an experimental cardiovascular drug designed to reduce inflammation.
Novo Nordisk faces a diverging trajectory as it meets pediatric obesity goals but terminates two heart disease drug trials.
Novartis and Bristol Myers Squibb halt autoimmune CAR-T trials following patient deaths, impacting the sector.
Novartis and Bristol Myers Squibb halt multiple CAR-T clinical trials for autoimmune diseases following patient deaths and safety reviews.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Lipoprotein(a) moves from lab curiosity to market‑ready target as new drugs and testing surge forward
Patients facing chronic illness report significant barriers to clinical trial enrollment, ranging from physician silence to financial burdens.
Coverage reveals a third death in opaque Chinese clinical trials involving CAR-T therapy, intensifying global scrutiny.
Health authorities and global outlets report ongoing rollout discussions and upcoming trials for Ebola vaccines in the DRC.
Recent studies and reports indicate that artificial intelligence is delivering substantial cost savings and efficiency to oncology clinical trials.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Pharmaceutical giant Novo Nordisk faces a significant setback following the failure of a late-stage cardiovascular drug trial.
Investigations are underway following a child's death in a gene-editing trial, flagged by Science-Retraction Watch reporting.
The world's first human clinical trial for a Bundibugyo ebolavirus vaccine has commenced following the first volunteer's vaccination.
Prediction market Kalshi is expanding its platform to allow users to wager on biotech clinical trial outcomes and FDA regulatory decisions.
UCSF has launched a novel clinical trial to determine if a combination of two drugs is more effective at treating Alzheimer's than a single medication.
A new oral GLP-1 receptor agonist is emerging as a potent weight-loss alternative, outperforming oral Ozempic in recent clinical trials.
Recent trial results indicate that two common medications may provide modest, short-term relief for long-COVID-related fatigue.